Pharmaceutical

SBTi approves Piramal Pharma’s GHG reduction targets

The SBTi has validated and approved India's Piramal Pharma’s near-term greenhouse gas (GHG) emission reduction targets.

Sep 18, 2024 - 04:00
SBTi approves Piramal Pharma’s GHG reduction targets
The SBTi has validated and approved India's Piramal Pharma’s near-term greenhouse gas (GHG) emission reduction targets.
Read the original article

Tags:

Previous Article

Sanofi begins shipping BEYFORTUS to US for RSV prevention in infants

Next Article

Long-Term Immunotherapy Benefits For Melanoma Shown in Ten-Year Survival Data

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Drug shortages and the supply chain are a matter of national security, experts say

STAT+: Drug shortages and the supply chain are a matter...

Nov 7, 2023

Opinion: The staggering financial burden of a proposed HIPAA rule

Opinion: The staggering financial burden of a proposed ...

Mar 19, 2023

Opinion: It’s long past time for a more comprehensive Covid treatment approach

Opinion: It’s long past time for a more comprehensive C...

Aug 31, 2023